Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abbott Laboratories (NY: ABT ) 107.53 +0.67 (+0.63%) Official Closing Price Updated: 7:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Abbott Laboratories < Previous 1 2 3 4 5 6 7 8 9 ... 29 30 Next > Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth April 25, 2024 Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions. Via Talk Markets Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes April 23, 2024 It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay. Via InvestorPlace 3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip April 22, 2024 These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more. Via InvestorPlace Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review April 19, 2024 The Nasdaq and S&P 500 tumbled below their 50-day lines. Via Investor's Business Daily Topics Stocks Exposures US Equities Behind the Scenes of Abbott Laboratories's Latest Options Trends April 18, 2024 Via Benzinga Abbott Laboratories Dividend Stock Analysis April 12, 2024 Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the... Via Talk Markets Abbott Laboratories Unusual Options Activity April 11, 2024 Via Benzinga Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday? April 17, 2024 A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as... Via Benzinga Topics Bonds Exposures Debt Markets Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript April 17, 2024 ABT earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024 April 17, 2024 ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS April 17, 2024 Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth. Via Talk Markets Analyst Ratings For Abbott Laboratories April 03, 2024 Via Benzinga Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings April 17, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report April 17, 2024 Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but shares fell. Via Investor's Business Daily Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance April 17, 2024 Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO... Via Benzinga Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point April 17, 2024 U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bullish market watchers pointed out there could be an... Via Benzinga Topics Stocks Exposures US Equities Earnings Scheduled For April 17, 2024 April 17, 2024 Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share on revenue of $6.13 billion. Via Benzinga Investor Optimism Decreases; Dow Ends 6-Session Losing Streak April 17, 2024 The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesday. U.S. stocks closed mixed on Tuesday amid increased... Via Benzinga Topics Stocks Exposures US Equities Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday April 17, 2024 With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead April 16, 2024 Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. Via Talk Markets 3 Buy Rated Stocks To Consider As Earnings Approach April 13, 2024 With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation. Via Talk Markets Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer April 12, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc. Via Benzinga Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit April 12, 2024 Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end? Via Investor's Business Daily Got $200? 2 Healthcare Stocks to Buy and Hold Forever. April 11, 2024 These companies provide stability, reliability, and passive income. Via The Motley Fool 7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape April 10, 2024 Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods. Via InvestorPlace Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' April 09, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over Via Benzinga 3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade April 09, 2024 Income-seeking investors can look forward to steady payout raises from these pharma stocks. Via The Motley Fool 3 Top Dividend Stocks to Buy in April 2024 April 06, 2024 Each of these high-quality stocks looks like a buy. Via The Motley Fool Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks April 06, 2024 Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW). Via Talk Markets FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries April 02, 2024 FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life.... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 9 ... 29 30 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.